Copyright
©The Author(s) 2024.
World J Exp Med. Mar 20, 2024; 14(1): 89319
Published online Mar 20, 2024. doi: 10.5493/wjem.v14.i1.89319
Published online Mar 20, 2024. doi: 10.5493/wjem.v14.i1.89319
Table 3 Univariate and multifactorial logistic regression analysis
Characteristic | Univariate analysis OR (95%CI) | P value | Multivariate analysis OR (95%CI) | P value |
Age (yr) | ||||
< 60 | 1 | - | ||
60-69 | 1.60 (0.51-5.02) | 0.420 | ||
≥ 70 | 1.24 (0.25-6.17) | 0.789 | ||
Tumor localization | ||||
Peripheral | 1 | - | ||
Central | 3.07 (0.85-11.07) | 0.089 | ||
Histology | ||||
KSCC | 1 | - | ||
NKSCC | 2.60 (0.84-8.07) | 0.101 | ||
Grade | ||||
G1 | 1 | - | 1 | - |
G2 | 0.59 (0.13-2.54) | 0.590 | 0.91 (0.44-4.56) | 0.345 |
G3 | 6.00 (1.01-67.28) | 0.0211 | 7.94 (1.08-135.81) | 0.0481 |
T stage | ||||
T1b | 1 | - | ||
T2a | 1.62 (0.25-10.36) | 0.622 | ||
T2b | 0.80 (0.08-8.47) | 0.853 | ||
T3 | 0.63 (0.10-3.95) | 0.631 | ||
N stage | ||||
N0 | 1 | - | 1 | - |
N1 | 5.63 (1.27-24.86) | 0.0231 | 5.67 (1.09-36.54) | 0.0481 |
N2 | 3.75 (0.77-18.21) | 0.101 | 6.30 (0.78-50.78) | 0.08 |
Stage | ||||
IIb | 1 | - | ||
IIIa | 1.44 (0.50-4.14) | 0.498 | ||
DCs of “contact type” | ||||
Presence | 1 | - | ||
Absence | 1.61 (0.53-4.91) | 0.404 | ||
The capillaries in the tumor solid component | ||||
Absence | 1 | - | ||
Presence | 2.24 (0.74-6.79) | 0.154 | ||
LFFCT in the tumor stroma | ||||
Absence | 1 | - | 1 | - |
Presence | 15.33 (3.56-66.04) | 0.00021 | 21.70 (4.27-110.38) | 0.00021 |
Fragmentation in the tumor solid component | ||||
Absence | 1 | - | 1 | - |
Presence | 3.42 (1.06-11.03) | 0.0401 | 2.53 (1.01-12.23) | 0.0491 |
Peritumoral retraction clefting | ||||
Absence | 1 | - | ||
Presence | 0.41 (0.13-1.30) | 0.13 | ||
Tumor spread in the AAS | ||||
Absence | 1 | - | ||
Presence | 1.08 (0.38-3.07) | 0.883 |
- Citation: Senchukova MA, Kalinin EA, Volchenko NN. Predictors of disease recurrence after radical resection and adjuvant chemotherapy in patients with stage IIb-IIIa squamous cell lung cancer: A retrospective analysis. World J Exp Med 2024; 14(1): 89319
- URL: https://www.wjgnet.com/2220-315x/full/v14/i1/89319.htm
- DOI: https://dx.doi.org/10.5493/wjem.v14.i1.89319